Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease

201842 citationsJournal Articlegold Open Access

Authors

Shani Cohen · Intel (Israel)

Zeev Waks · Intel (Israel)

Jordan J. Elm · Medical University of South Carolina

Mark Forrest Gordon · Teva Pharmaceuticals (United States)

Igor D. Grachev

Leehee Navon-Perry · Teva Pharmaceuticals (Israel)

Shai Fine · Reichman University

Abstract

Trials described in this study include a sub-study of the Open PRIDE-HD Huntington's disease study (TV7820-CNS-20016), which was registered on July 7th, 2015, sponsored by Teva Pharmaceuticals Ltd., and registered on Clinicaltrials.gov as NCT02494778 and EudraCT as 2015-000904-24 .

Topics & Keywords

Medication Adherence and Compliance Bipolar Disorder and Treatment Parkinson's Disease Mechanisms and Treatments

Publication Details

Published in: BMC Medical Informatics and Decision Making

Volume 18, Issue 1, pp. 138-138

DOI: 10.1186/s12911-018-0714-7

Field-Weighted Citation Impact: 2.44

Command Palette

Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease

Authors

Abstract

Topics & Keywords

Publication Details